Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 7, 2017; 23(29): 5282-5294
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5282
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5282
Figure 4 Combined hepatocellular-cholangiocarcinoma with stem cell features, intermediate cell subtype.
Tumor expresses both hepatocellular (HepPar1) and biliary (CK19) immunohistochemical markers. A: H/E × 100; B: HepPar1 × 100; C: CK19 × 100.
- Citation: Dimitroulis D, Damaskos C, Valsami S, Davakis S, Garmpis N, Spartalis E, Athanasiou A, Moris D, Sakellariou S, Kykalos S, Tsourouflis G, Garmpi A, Delladetsima I, Kontzoglou K, Kouraklis G. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol 2017; 23(29): 5282-5294
- URL: https://www.wjgnet.com/1007-9327/full/v23/i29/5282.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i29.5282